As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 21, 2013
by The Japan Times:
The devastating effect of Alzheimer’s disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Despite increasing evidence that bilingualism can actually delay the onset of dementia, those grappling with the ravages of the disease often find themselves isolated by the lack of essential services in their language of choice.
When Alzheimer’s strikes, a person’s people’s ability to communicate in their second language often erodes rapidly.
Sylvie Lavoie said she noticed a steady deterioration in her mother’s ability to speak English fluently after she was diagnosed with the disease.
Her mother, Helene Tremblay-Lavoie, later took a test to measure her deterioration that provided conclusive evidence.
She scored nine marks out of 30 for a test in English contrasted with 19 out of 30 for the same test in French.
“The result was a terrible shock, a huge surprise,” Lavoie said. “Talking in French to my mother I had not noticed that she had lost her English.
“I noticed that she was speaking less and less English to my husband, who is anglophone, but I attributed that to the illness and general fatigue.”
The case garnered attention in Canada. Tremblay-Lavoie was born in the French-speaking province of Quebec and lived in Toronto for 30 years, becoming fully bilingual.
However, when it came to finding a facility capable of caring for her mother, Lavoie discovered nothing was available for her mother in Toronto.
She eventually found a spot in a French-speaking hospice in the town of Welland, near Niagara Falls.
In response to the shortfall of spaces, the Helene Tremblay-Lavoie Foundation was set up last year with the goal of creating long-term care for francophones in the Toronto region.
“People who lose the ability to speak English are unilingual francophones who have learned English later in life,” said Guy Proulx, a professor at York University who specializes in the assessment and rehabilitation of cognitive disorders in people suffering from strokes or dementia.
Proulx, a director of the foundation, cautioned that individuals who had been bilingual since childhood were less likely to lose the use of their second language.
“A bilingual from childhood won’t lose it because it is automated, it is anchored in. When it is automated, it is more resistant to diseases like Alzheimer’s,” he explained.
Proulx and the foundation are hoping to set up a dedicated francophone clinic in the Toronto region that will feature a research center in the field of cognitive health and therapy for diseases like Alzheimer’s.
Nearly 90 percent of francophones in Toronto — some 125,000 people out of a population of 600,000 across Ontario — are in relationships with nonfrancophones.
The aim is to ensure these people can stay together when the disease strikes.
“Health care services in French are available in Toronto but they are scattered. They need to be structured,” said Proulx.
Jean Roy, who chairs the foundation’s board, said it had the support of the provincial and federal governments.
“The project will cost 200,000 Canadian dollars ($195,000) per year for three years and we already have the money,” Roy said. “It is only going to be a matter of months.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.